Journal Title
LEUKEMIA & LYMPHOMA

LEUKEMIA LYMPHOMA

ISSN / eISSN
1042-8194 / 1029-2403
Aims and Scope
Leukemia & Lymphoma in its fourth decade continues to provide an international forum for publication of high quality clinical, translational, and basic science research, and original observations relating to all aspects of hematological malignancies. The scope ranges from clinical and clinico-pathological investigations to fundamental research in disease biology, mechanisms of action of novel agents, development of combination chemotherapy, pharmacology and pharmacogenomics as well as ethics and epidemiology. Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor
Subject Area

HEMATOLOGY

ONCOLOGY

CiteScore
4.10 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Hematology Q2 #67/137
Medicine - Oncology Q2 #201/404
Medicine - Cancer Research Q3 #149/230
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
HEMATOLOGY Q3
ONCOLOGY Q3
H-index
82
Country/Area of Publication
ENGLAND
Publisher
Informa Healthcare
Publication Frequency
Monthly
Year Publication Started
1989
Annual Article Volume
174
Open Access
NO
Contact
TAYLOR & FRANCIS LTD, 4 PARK SQUARE, MILTON PARK, ABINGDON, ENGLAND, OXON, OX14 4RN
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
Notification of format change one week after submission on October 9th. Major revisions on November 3rd. Revised version submitted on December 6th. Minor revisions made on the same day as December 16th. Acceptance on December 20th. Not sure when it will be available online. The reviewer is quite diligent and professional.
2021-12-25

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started